Anxiolytic Pre-IRM Administration

Introduction to Lorazepam Administration

• The American College of Emergency Physicians recommends administering lorazepam 0.5-1 mg sublingually 60-90 minutes before the procedure for anxious patients, with a reduced dose of 0.25-0.5 mg for elderly or frail patients 1, 2

Posology

• For adults under 65, the standard dose is 0.5-1 mg sublingually, with a maximum dose of 4 mg in 24 hours 1, 2, 3, 4, 5
• The dose may be adjusted based on the severity of anxiety, weight, and previous exposure to benzodiazepines 2

Special Populations

• For elderly or frail patients, the recommended dose is 0.25-0.5 mg sublingually, with a maximum dose of 2 mg in 24 hours 1, 2, 3, 4, 5

Timing of Administration

• Administer lorazepam 60-90 minutes before the IRM procedure to allow for maximum effect 1
• Allow 30-60 minutes for the full effect to appear to avoid premature re-dosing 2

Alternatives

• If the patient cannot swallow or use the sublingual route, midazolam 2.5-5 mg subcutaneously every 2-4 hours as needed may be used 3, 4, 5

Surveillance and Precautions

• Continuous oxygen saturation monitoring is required during the procedure and recovery period 2
• Equipment for respiratory support should be immediately available, as benzodiazepines increase the risk of apnea 2
• Monitor for hypotension, particularly in elderly or fragile patients 2
• Have flumazenil available to reverse potentially life-threatening respiratory depression 2

Recommendations from Guideline Societies

• The American College of Emergency Physicians and the British Medical Journal support lorazepam as the first-line choice for procedural anxiety, with flexibility in administration critical when patients experience severe anxiety before procedures 1
• The American Geriatrics Society specifically recommends reduced dosing for elderly patients 1